Feature

Immunotherapy moves into the breast cancer landscape


 

At this year’s San Antonio Breast Cancer Symposium, investigators presented some encouraging findings for difficult-to-treat patient populations, but issues such as therapy side effects and fertility concerns in younger patients also highlighted the importance of looking closely at the risk-benefit relationship in delivering quality, personalized care to patients with breast cancer.

Click on the PDF icon at the top of this introduction to read the full article.

Next Article: